(19 March 2025)
The efficacy of islet autoantibody screening with or without genetic pre-screening strategies for the identification of presymptomatic type 1 diabetes
Ezio Bonifacio, Raquel Coelho, Domenik A. Ewald, Gita Gemulla, Michael Hubmann, Przemyslawa Jarosz‑Chobot, Mirjam Kohls, Olga Kordonouri, Vito Lampasona, Parth Narendran, Flemming Pociot, Zdenek Šumník, Agnieszka Szypowska, Jose Zapardiel‑Gonzalo, Anette‑Gabriele Ziegler.
Diabetologia (2025). https://doi.org/10.1007/s00125-025-06408-4
(2 January 2025)
EDENT1FI Master Protocol for screening of presymptomatic early-stage type 1 diabetes in children and adolescents
Hoffmann L, Kohls M, Arnolds S, Achenbach P, Bergholdt R, Bonifacio E, Bosi E, Gündert M, Hoefelschweiger BK, Hummel S, Jarosz-Chobot P, Kordonouri O, Lampasona V, Narendran P, Overbergh L, Pociot F, Raposo JF, Šumník Z, Szypowska A, Vercauteren J, Winkler C, Mathieu C, Ziegler AG; EDENT1FI consortium.
BMJ Open. 2025 Jan 2;15(1):e088522. doi: 10.1136/bmjopen-2024-088522. PMID: 39753267
(19 September 2024)
Type 1 Diabetes can be fast, but we can be faster! A call to boost early detection
(26 August 2024)
Transitioning to stage 3 type 1 diabetes: when to start insulin.
Rachel E J Besser, Kurt J Griffin
Lancet Diabetes Endocrinol. 2024 Oct;12(10):692-694. doi: 10.1016/S2213-8587(24)00238-9. Epub 2024 Aug 26.PMID: 39208831
(02 November 2023)
European Partnership to Combat Type 1 Diabetes Receives €23 Million IHI Funding
(01 November 2023)
KULeuven Drives Change: EDENT1FI's European Synergy Shaping the Future of Identifying Type 1 Diabetes in Children